Prediction of lung tumor types based on protein attributes by machine learning algorithms

Abstract

Early diagnosis of lung cancers and distinction between the tumor types (Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC) are very important to increase the survival rate of patients. Herein, we propose a diagnostic system based on sequence-derived structural and physicochemical attributes of proteins that involved in both types of tumors via feature extraction, feature selection and prediction models. 1497 proteins attributes computed and important features selected by 12 attribute weighting models and finally machine learning models consist of seven SVM models, three ANN models and two NB models applied on original database and newly created ones from attribute weighting models; models accuracies calculated through 10-fold cross and wrapper validation (just for SVM algorithms). In line with our previous findings, dipeptide composition, autocorrelation and distribution descriptor were the most important protein features selected by bioinformatics tools. The algorithms performances in lung cancer tumor type prediction increased when they applied on datasets created by attribute weighting models rather than original dataset. Wrapper-Validation performed better than X-Validation; the best cancer type prediction resulted from SVM and SVM Linear models (82%). The best accuracy of ANN gained when Neural Net model applied on SVM dataset (88%). This is the first report suggesting that the combination of protein features and attribute weighting models with machine learning algorithms can be effectively used to predict the type of lung cancer tumors (SCLC and NSCLC).Electronic supplementary materialThe online version of this article (doi:10.1186/2193-1801-2-238) contains supplementary material, which is available to authorized users.

Machine learning is a valid method for predicting prehospital delay after acute ischemic stroke

“…Machine learning (ML) learns from observed data using a variety of artificial intelligence and statistical models to establish rational generalizations, discover patterns, classify unknown data, or predict new directions (Hosseinzadeh, Kayvanjoo, Ebrahimi, & Goliaei, 2013). ML methodologies, such as the Bayesian network (BN) and support vector machine (SVM), are being rapidly adopted in the medical field, because they enhance the practicability of classification and prediction.…”

Evaluation of Machine Learning Algorithm Utilization for Lung Cancer Classification Based on Gene Expression Levels

“…However, SVM showed second result after Bayes tree algorithm in identification and validation of the methylation biomarkers of nonsmall cell lung cancer (Guo et al, 2015). In addition it is effectively used to predict lung cancer type between small-cell one and non-small cell one, for example, in study Hosseinzadeh et al (2013) SVM showed the best accuracy in analysis of protein attributes.…”

Prediction of hepatitis C virus interferon/ribavirin therapy outcome based on viral nucleotide attributes using machine learning algorithms

“…The current study aimed to analyse nucleotide sequences of HCV isolates from responders, non-responders, and relapsers aiming to generate decision trees for the prediction of treatment outcome. Recently, we have shown that the comparison of large numbers of sequences using mining techniques (such as decision tree) generated supervised and unsupervised models suitable for identification of novel proteins involved in the malignancy of breast cancer and lung cancer [ 29 , 30 ] and genetic markers for characterization of olive cultivars [ 20 ]. Using the same approach, we identified new genetic determinants that play important functional roles in the thermostable proteins [ 31 ], halostable proteins [ 32 ], and P1B-ATPase heavy metal transporters [ 21 ].…”